This message contains images. If you don't see images, click here to view. Click here to advertise in this news brief.   Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit Home   About   Scholarships   Meetings   Publications   Resources   Nov. 27, 2012   US panel recommends more routine HIV testing The Associated Press via TIME    Share    Widespread testing of most healthy adults would curb spread of the disease by bringing more patients into early treatment. Americans ages 15 to 64 should get an HIV test at least once — not just people considered at high risk for the virus, an independent panel that sets screening guidelines proposed. More We've got you covered Dealing with infectious samples is risky enough. Why increase your risk by overlooking transport regulations? Saf-T-Pak provides the solutions required for 49 CFR compliance: Compliance Training for Shipping Division 6.2 Infectious Substances Compliant Packaging (Category A, Category B, Exempt and Temperature Controlled shipping systems) Study: 1.3 million overdiagnosed breast cancers in 30 years Medscape Medical News    Share    In the past 30 years, an estimated 1.3 million American women had breast cancers that were "overdiagnosed," which means their screening-detected tumors would never have led to clinical symptoms, according to a study published in the New England Journal of Medicine. In 2008 alone, breast cancer was overdiagnosed in an estimated 70,000-plus women, which was 31 percent of all breast cancers diagnosed that year, assert the study authors, Archie Bleyer, M.D., from the Oregon Health and Science University in Portland, and H. Gilbert Welch, M.D., from the Geisel School of Medicine at Dartmouth College in Hanover, N.H. More Bacterial DNA sequence used to map disease outbreak domain-b.com    Share    For the first time, researchers have used DNA sequencing to help bring an infectious disease outbreak in a hospital to a close. Researchers from the Wellcome Trust Sanger Institute, the University of Cambridge and Cambridge University Hospitals used advanced DNA sequencing technologies to confirm the presence of an ongoing outbreak of methicillin-resistant Staphylococcus aureus in a "special care baby unit" in real time. More New test may improve cervical cancer detection University of Gothenburg via Medical Xpress    Share    Routine smear tests have considerably reduced the number of cases of cervical cancer, but despite intensive screening 250 women in Sweden still die from the disease every year. Researchers at Sahlgrenska Academy, University of Gothenburg, Sweden, have developed new methods of minimizing the number of missed cases and making diagnosis more reliable. More Latest WHO warning about new coronavirus raises transparency concerns for health experts The Canadian Press via Toronto Star    Share    The World Health Organization has warned countries to heighten their surveillance for possible cases of infection with the new coronavirus, suggesting patients with unexplained pneumonias should be tested even if they don't have links to Saudi Arabia and Qatar. The agency also suggested investigating clusters of severe respiratory infections and clusters of such illnesses in health care workers, regardless of where they occur in the world. More Rethinking HIV: After 5 years of debate, a new push for prevention TIME    Share    After decades of focusing almost exclusively on treating HIV, public health experts are now considering a new approach, moving to establish more effective prevention strategies to curb spread of the disease. Recent tests show that anti-HIV drugs that can hamper the growth of the virus responsible for AIDS may also prevent progression of the disease if given to infected individuals soon after their exposure to HIV. More 'Medical laboratory without walls' takes molecular diagnostics testing to remote places down under Dark Daily    Share    An Australian pathologist is pioneering a new approach for showcasing the role of pathology and demonstrating the dramatic potential of mobile medical laboratories. His technique: take a molecular diagnostics laboratory on the road — in a suitcase. More CellaVision Automates and Standardizes the Manual Differential CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More Triturus - True Open Flexibility As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing. 1-800-379-0957. diaginfo@grifols.com Trust in Cleveland Clinic Laboratories Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com. FDA panel endorses novel hepatitis vaccine efficacy, not safety Medscape Medical News    Share    A federal advisory panel has voted to support the effectiveness but not the safety of a novel hepatitis B vaccine for adults aged 18 to 70 years. The panel's main concerns were that the safety database was too small to detect rare adverse events, that the vaccine hadn't been studied in sufficient numbers of ethnic minority populations and that it hadn't been studied in combination with the administration of other adult vaccines. More Fighting cancer with cell phones: Innovation to save lives in Africa CNN    Share    Only innovation can reduce illness and poverty in Africa, according to a program that is funding creative approaches to health care in developing countries. More than 50,000 women die each year of cervical cancer in Africa, according to World Health Organization estimates, as more than 80 percent of the cases are detected in late stages. In countries such as Tanzania, where nearly 4,500 women die annually from the disease, the problem is exacerbated by an acute shortage of medical experts and a lack of quality screening services, especially in rural areas. More Repeat testing common in older patients MedPage Today    Share    Despite widespread concern about health care costs, many doctors order repeat diagnostics even though the value of the extra testing is uncertain, researchers found. In a large cohort of Medicare beneficiaries, the rate of such tests repeated within three years ranged from a third to a half, even though such repetition would not be routinely expected, according to researchers. More CDC reports increase in non-meningitis infections tied to outbreak CBS News    Share    A 19-state outbreak tied to contaminated steroid injections is growing in cases of those who have been infected, however the new increase appears to more pronounced in non-meningitis infections. There have been 478 cases of fungal meningitis or related infections, according to the Centers for Disease Control and Prevention, plus 12 peripheral joint infections in areas such as the knees, hips, shoulders and elbows where people may have gotten the shots. More Panel recommends routine HIV tests for teens, adults USA Today    Share    In a broad new expansion of HIV screening, an influential government panel says everyone ages 15 to 65 should be tested for the virus that causes AIDS. The draft recommendation, issued recently by the U.S. Preventive Services Task Force, is far broader than its last recommendation in 2005, which called for screening only those at high risk. More Animal testing may be overtaken by 'organ-on-a-chip' Medical News Today    Share    A U.S. study that successfully used a "lung-on-a-chip" to mimic a chemotherapy drug side effect brings closer the day when drug developers use "organ-on-a-chip" methods to replace more traditional approaches like animal testing and cell cultures, which are costly and time-consuming. More   ASCLS eNewsBytes Colby Horton, Vice President of Publishing, 469.420.2601 Download media kit Bob Kowalski, Content Editor, 469.420.2650    Contribute news This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free! Recent issues Nov. 20, 2012 Nov. 15, 2012 Nov. 13, 2012 Nov. 6, 2012 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063